RetroVirox
About:
RetroVirox is a privately-held biotechnology company dedicated to discovering new treatments for patients with infectious diseases
Website: http://retrovirox.com
Top Investors: National Institutes of Health
Description:
RetroVirox is an innovative, privately-held biotechnology company dedicated to discovering new treatments for patients with infectious disease. RetroVirox offers its expertise in antiviral assays and cell-based screening for antiviral compounds to other biotechnology and pharmaceutical companies.
Total Funding Amount:
$3M
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
San Diego, California, United States
Founded Date:
2008-01-01
Contact Email:
info(AT)retrovirox.com
Founders:
Enric Bernal, Juan Lama
Number of Employees:
1-10
Last Funding Date:
2015-03-12
IPO Status:
Private
Industries:
© 2025 bioDAO.ai